Genetics, functions, and clinical impact of presenilin-1 (PSEN1) gene

J Bagaria, E Bagyinszky, SSA An - International Journal of Molecular …, 2022 - mdpi.com
Presenilin-1 (PSEN1) has been verified as an important causative factor for early onset
Alzheimer's disease (EOAD). PSEN1 is a part of γ-secretase, and in addition to amyloid …

The genetics of Alzheimer's disease

E Bagyinszky, YC Youn, SSA An… - Clinical interventions in …, 2014 - Taylor & Francis
Alzheimer's disease (AD) is a complex and heterogeneous neurodegenerative disorder,
classified as either early onset (under 65 years of age), or late onset (over 65 years of age) …

The age factor in Alzheimer's disease

R Guerreiro, J Bras - Genome medicine, 2015 - Springer
Alzheimer's disease is the most common type of dementia, and it is characterized by a
decline in memory or other thinking skills. The greatest risk factor for Alzheimer's disease is …

[HTML][HTML] Doença de Alzheimer: hipóteses etiológicas e perspectivas de tratamento

AD Falco, DS Cukierman, RA Hauser-Davis, NA Rey - Química Nova, 2016 - SciELO Brasil
With the increase in life expectancy registered in the past few decades, the prevalence of
various medical conditions related to aging has been observed, such as dementia and …

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

C Patterson, JW Feightner, A Garcia, GYR Hsiung… - Cmaj, 2008 - Can Med Assoc
Background: In addition to nonmodifiable genetic risk factors, potentially modifiable factors
such as hypertension, hyperlipidemia and environmental exposures have been identified as …

Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2

S Jayadev, JB Leverenz, E Steinbart, J Stahl, W Klunk… - Brain, 2010 - academic.oup.com
Mutations in presenilin 2 are rare causes of early onset familial Alzheimer's disease.
Eighteen presenilin 2 mutations have been reported, although not all have been confirmed …

Redox signaling and metabolism in Alzheimer's disease

MI Holubiec, M Gellert… - Frontiers in Aging …, 2022 - frontiersin.org
Reduction and oxidation reactions are essential for biochemical processes. They are part of
metabolic pathways and signal transduction. Reactive oxygen species (ROS) as second …

Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders

Y Cai, SSA An, SY Kim - Clinical interventions in aging, 2015 - Taylor & Francis
Alzheimer's disease (AD) is the most common form of dementia. Mutations in the genes
encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have …

Genetics of Alzheimer's disease: a centennial review

N Ertekin-Taner - Neurologic clinics, 2007 - Elsevier
Alzheimer's disease (AD) genetics may be one of the most prolifically published areas in
medicine and biology. Three early-onset AD genes with causative mutations (APP, PSEN1 …

[HTML][HTML] A systematic review of familial Alzheimer's disease: Differences in presentation of clinical features among three mutated genes and potential ethnic …

YF Shea, LW Chu, AOK Chan, J Ha, Y Li… - Journal of the Formosan …, 2016 - Elsevier
There are great diversities of clinical phenotypes among the various familial Alzheimer's
disease (FAD) families. We aimed to systematically review all the previously reported cases …